Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3460473 | 0.83 | ALDH1A1 (0.30) | — | |
| SCHEMBL11630500 | 0.81 | — | — | |
| SCHEMBL818370 | 0.78 | TSHR (0.40) | — | |
| SCHEMBL818423 | 0.78 | TSHR (0.33) | — | |
| SCHEMBL2839055 | 0.76 | — | — | |
| SCHEMBL2847434 | 0.74 | — | — | |
| SCHEMBL1094410 | 0.74 | TSHR (0.32) | — | |
| SCHEMBL18040900 | 0.74 | — | — | |
| SCHEMBL54993 | 0.74 | — | — | |
| Iodide SCHEMBL28716865 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022207920-A1 | MULTIBRANCHED POLYMERS, COMPOSITIONS COMPRISING SAME, METHODS FOR PREPARING SAME, AND USE THEREOF IN ELECTROCHEMISTRY | SCE FRANCE (FR) | 2022-10-06 | — | — | WO | claimed |
| EP-1794204-B1 | WATER-DISPERSIBLE HIGHLY FUNCTIONAL POLYISOCYANATES | BASF SE (DE) | 2011-03-16 | — | — | EP | claimed |
| US-7645855-B2 | Condensation, solution polymerization of carbonates with diamines | BASF AKTIENGESELLSCHAFT (DE) | 2010-01-12 | — | — | US | claimed |
| EP-2111236-A2 | NOVEL CASCADE POLYMER COMPLEXES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THE SAME | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-10-28 | — | — | EP | claimed |
| WO-2009027186-A2 | HYPERBRANCHED POLYMERS COMPRISING GUANIDINE UNITS | BASF SE (DE) | 2009-03-05 | — | — | WO | claimed |
| US-20080306237-A1 | Highly Functional, Highly Branched Polyureas | BASF AKTIENGESELLSCHAFT (DE) | 2008-12-11 | — | — | US | claimed |
| EP-1716197-B1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF SE (DE) | 2008-10-29 | — | — | EP | claimed |
| US-20080213187-A1 | NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | EPIX PHARMACEUTICALS, INC. | 2008-09-04 | — | — | US | claimed |
| EP-1685181-B1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF SE (DE) | 2008-08-20 | — | — | EP | claimed |
| WO-2008087017-A2 | NOVEL CASCADE POLYMER COMPLEXES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THE SAME | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-07-24 | — | — | WO | claimed |
| WO-2006032424-A1 | WATER-DISPERSIBLE HIGHLY FUNCTIONAL POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-30 | — | — | WO | claimed |
| WO-2005075541-A1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-18 | — | — | WO | claimed |
| EP-1563014-A1 | OPTICAL DATA MEMORIES COMPRISING COBALT PHTALOCYANIN WITH AN AXIAL SUBSTITUENT AND AXIAL LIGAND IN AN INFORMATION PHOTOINSCRIBTIBLE LAYER | LANXESS Deutschland GmbH (DE) | 2005-08-17 | — | — | EP | claimed |
| WO-2005044897-A1 | HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-19 | — | — | WO | claimed |
| WO-2004046253-A1 | OPTICAL DATA MEMORIES COMPRISING COBALT PHTALOCYANIN WITH AN AXIAL SUBSTITUENT AND AXIAL LIGAND IN AN INFORMATION PHOTOINSCRIBTIBLE LAYER | LANXESS DEUTSCHLAND GMBH (DE) | 2004-06-03 | — | — | WO | claimed |
| US-20020007036-A1 | High-functionality polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-17 | — | — | US | claimed |
| EP-1134247-A2 | Highfunctionality polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-19 | — | — | EP | claimed |
| US-6193950-B1 | FOR DIAGNOSIS AND THERAPY | SCHERING AG (DE) | 2001-02-27 | — | — | US | claimed |
| US-5650136-A | Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-07-22 | — | — | US | claimed |
| US-4775734-A | Non-nucleophilic acid salts of amines as cure accelerators | ASHLAND OIL, INC. (US) | 1988-10-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020007036-A1 | High-functionality polyisocyanates | PCBP1, C9, CYP1B1 | LAP3 1759/4885 |
| US-20080213187-A1 | NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PGF, F13A1, F11 | LAP3 2222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.